Ovarian cancer MRI: Difference between revisions
Jump to navigation
Jump to search
Hudakarman (talk | contribs) |
|||
| Line 19: | Line 19: | ||
'''[[Ovarian serous cystadenocarcinoma]]''' | '''[[Ovarian serous cystadenocarcinoma]]''' | ||
*[[MRI]] is the modality of choice in the characterization of [[ovarian malignancy]] and in the detection of [[lymphatic]], [[peritoneal]], and distant [[metastases]] | *[[MRI]] is the modality of choice in the characterization of [[ovarian malignancy]] and in the detection of [[lymphatic]], [[peritoneal]], and distant [[metastases]]. | ||
*Both for [[Preoperative evaluation|preoperative]] planning and post-treatment follow up. | *Both for [[Preoperative evaluation|preoperative]] planning and post-treatment follow up. | ||
*The cystic components | *The cystic components | ||
| Line 32: | Line 32: | ||
**On T1-weighted images, loculi with watery mucin have a lower signal intensity than loculi with thicker mucin. | **On T1-weighted images, loculi with watery mucin have a lower signal intensity than loculi with thicker mucin. | ||
*T2 | *T2 | ||
** | **On T2-weighted images, the corresponding signal intensities are flipped, so that loculi with watery mucin have a high signal intensity and loculi with thicker mucin appear slightly hypointense. | ||
*[[MRI]] | *[[MRI]] | ||
*Often seen as a cystic [[ovarian mass]] with the margin being generally smooth. Solid protrusions are often both round and few in number. | *Often seen as a cystic [[ovarian mass]] with the margin being generally smooth. Solid protrusions are often both round and few in number. | ||
Latest revision as of 15:32, 13 September 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2] Huda A. Karman, M.D.
|
Ovarian cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ovarian cancer MRI On the Web |
|
American Roentgen Ray Society Images of Ovarian cancer MRI |
Overview
MRI of the pelvis, abdomen, and chest can be helpful as one of the evaluating tools of ovarian cancer and its extent and metastasis. CT scan be used for preoperative staging to look for lymphadenopathy, peritoneal, and distant metastases.
MRI
Endometrioid carcinoma of the ovary
Pelvic MRI: Reported signal characteristics include:
- T2:
- Relatively low signal intensity of the tumor wall
- Shading sign may be seen
- T1C+(Gd):
- Can show mild enhancement
Ovarian serous cystadenocarcinoma
- MRI is the modality of choice in the characterization of ovarian malignancy and in the detection of lymphatic, peritoneal, and distant metastases.
- Both for preoperative planning and post-treatment follow up.
- The cystic components
- Are high T2, low T1 signal
- If there has been intralesional hemorrhage (c.f. mucinous cystadenocarcinoma, there is typically slightly increased T1 signal of the cystic component)
- Solid malignant components
- Demonstrate intermediate T1 and T2 signal, restricted diffusion, and gadolinium enhancement.
- DWI is useful for the detection of distant metastases.
Ovarian mucinous cystadenocarcinoma
- T1:
- The signal intensity of mucin on T1-weighted images varies depending on the degree of mucin concentration
- On T1-weighted images, loculi with watery mucin have a lower signal intensity than loculi with thicker mucin.
- T2
- On T2-weighted images, the corresponding signal intensities are flipped, so that loculi with watery mucin have a high signal intensity and loculi with thicker mucin appear slightly hypointense.
- MRI
- Often seen as a cystic ovarian mass with the margin being generally smooth. Solid protrusions are often both round and few in number.
- Reported signal characteristics include:
- T1: can vary from low to very high (often dependent on the hemorrhagic component(s), not a specific feature)